Sign in
4

Changes in Ownership

Outlook Therapeutics, Inc. Filed Acc 0001209191-23-024879

Options or other derivatives

  • CEO and President acquired 257,143 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

TRENARY C RUSSELL III · CEO and President

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-04-17 Grant or award : show line 1 in the form Stock Option (Right to Buy) +257,143 257,143 D
Loading xslF345X04/doc4.xml…